<div class="container">

<table style="width: 100%;"><tr>
<td>getADRCI</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Repeated confidence interval after adaptation</h2>

<h3>Description</h3>

<p>Obtains the repeated p-value, conservative point estimate,
and repeated confidence interval for an adaptive group sequential trial.
</p>


<h3>Usage</h3>

<pre><code class="language-R">getADRCI(
  L = NA_integer_,
  zL = NA_real_,
  IMax = NA_real_,
  kMax = NA_integer_,
  informationRates = NA_real_,
  efficacyStopping = NA_integer_,
  criticalValues = NA_real_,
  alpha = 0.025,
  typeAlphaSpending = "sfOF",
  parameterAlphaSpending = NA_real_,
  spendingTime = NA_real_,
  L2 = NA_integer_,
  zL2 = NA_real_,
  INew = NA_real_,
  MullerSchafer = 0L,
  informationRatesNew = NA_real_,
  efficacyStoppingNew = NA_integer_,
  typeAlphaSpendingNew = "sfOF",
  parameterAlphaSpendingNew = NA_real_,
  spendingTimeNew = NA_real_
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>L</code></td>
<td>
<p>The interim adaptation look of the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>zL</code></td>
<td>
<p>The z-test statistic at the interim adaptation look of
the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>IMax</code></td>
<td>
<p>The maximum information of the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>kMax</code></td>
<td>
<p>The maximum number of stages of the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>informationRates</code></td>
<td>
<p>The information rates of the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>efficacyStopping</code></td>
<td>
<p>Indicators of whether efficacy stopping is
allowed at each stage of the primary trial. Defaults to true
if left unspecified.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>criticalValues</code></td>
<td>
<p>The upper boundaries on the z-test statistic scale
for efficacy stopping for the primary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>The significance level of the primary trial.
Defaults to 0.025.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>typeAlphaSpending</code></td>
<td>
<p>The type of alpha spending for the primary
trial. One of the following:
"OF" for O'Brien-Fleming boundaries,
"P" for Pocock boundaries,
"WT" for Wang &amp; Tsiatis boundaries,
"sfOF" for O'Brien-Fleming type spending function,
"sfP" for Pocock type spending function,
"sfKD" for Kim &amp; DeMets spending function,
"sfHSD" for Hwang, Shi &amp; DeCani spending function, and
"none" for no early efficacy stopping.
Defaults to "sfOF".</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>parameterAlphaSpending</code></td>
<td>
<p>The parameter value of alpha spending
for the primary trial. Corresponds to Delta for "WT", rho for "sfKD",
and gamma for "sfHSD".</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>spendingTime</code></td>
<td>
<p>The error spending time of the primary trial.
Defaults to missing, in which case, it is the same as
<code>informationRates</code>.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>L2</code></td>
<td>
<p>The look of interest in the secondary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>zL2</code></td>
<td>
<p>The z-test statistic at the look of the secondary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>INew</code></td>
<td>
<p>The maximum information of the secondary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>MullerSchafer</code></td>
<td>
<p>Whether to use the Muller and Schafer (2001) method
for trial adaptation.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>informationRatesNew</code></td>
<td>
<p>The spacing of looks of the secondary trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>efficacyStoppingNew</code></td>
<td>
<p>The indicators of whether efficacy stopping is
allowed at each look of the secondary trial up to look <code>L2</code>.
Defaults to true if left unspecified.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>typeAlphaSpendingNew</code></td>
<td>
<p>The type of alpha spending for the secondary
trial. One of the following:
"OF" for O'Brien-Fleming boundaries,
"P" for Pocock boundaries,
"WT" for Wang &amp; Tsiatis boundaries,
"sfOF" for O'Brien-Fleming type spending function,
"sfP" for Pocock type spending function,
"sfKD" for Kim &amp; DeMets spending function,
"sfHSD" for Hwang, Shi &amp; DeCani spending function, and
"none" for no early efficacy stopping.
Defaults to "sfOF".</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>parameterAlphaSpendingNew</code></td>
<td>
<p>The parameter value of alpha spending
for the secondary trial. Corresponds to Delta for "WT",
rho for "sfKD", and gamma for "sfHSD".</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>spendingTimeNew</code></td>
<td>
<p>The error spending time of the secondary trial.
up to look <code>L2</code>. Defaults to missing, in which case, it is
the same as <code>informationRatesNew</code>.</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>A data frame with the following variables:
</p>

<ul>
<li> <p><code>pvalue</code>: Repeated p-value for rejecting the null hypothesis.
</p>
</li>
<li> <p><code>thetahat</code>: Point estimate of the parameter.
</p>
</li>
<li> <p><code>cilevel</code>: Confidence interval level.
</p>
</li>
<li> <p><code>lower</code>: Lower bound of repeated confidence interval.
</p>
</li>
<li> <p><code>upper</code>: Upper bound of repeated confidence interval.
</p>
</li>
</ul>
<h3>Author(s)</h3>

<p>Kaifeng Lu, <a href="mailto:kaifenglu@gmail.com">kaifenglu@gmail.com</a>
</p>


<h3>References</h3>

<p>Cyrus R. Mehta, Peter Bauer, Martin Posch and Werner Brannath.
Repeated confidence intervals for adaptive group sequential trials.
Stat Med. 2007;26:5422â€“5433.
</p>


<h3>See Also</h3>

<p><code>adaptDesign</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R">
# original group sequential design with 90% power to detect delta = 6
delta = 6
sigma = 17
n = 282
(des1 = getDesign(IMax = n/(4*sigma^2), theta = delta, kMax = 3,
                  alpha = 0.05, typeAlphaSpending = "sfHSD",
                  parameterAlphaSpending = -4))

# interim look results
L = 1
n1 = n/3
delta1 = 4.5
sigma1 = 20
zL = delta1/sqrt(4/n1*sigma1^2)

t = des1$byStageResults$informationRates

# Muller &amp; Schafer (2001) method to design the secondary trial:
des2 = adaptDesign(
  betaNew = 0.2, L = L, zL = zL, theta = 5,
  kMax = 3, informationRates = t,
  alpha = 0.05, typeAlphaSpending = "sfHSD",
  parameterAlphaSpending = -4,
  MullerSchafer = TRUE,
  kNew = 3, typeAlphaSpendingNew = "sfHSD",
  parameterAlphaSpendingNew = -2)

n2 = ceiling(des2$secondaryTrial$overallResults$information*4*20^2)
ns = round(n2*(1:3)/3)
(des2 = adaptDesign(
  INew = n2/(4*20^2), L = L, zL = zL, theta = 5,
  kMax = 3, informationRates = t,
  alpha = 0.05, typeAlphaSpending = "sfHSD",
  parameterAlphaSpending = -4,
  MullerSchafer = TRUE,
  kNew = 3, informationRatesNew = ns/n2,
  typeAlphaSpendingNew = "sfHSD",
  parameterAlphaSpendingNew = -2))

# termination at the second look of the secondary trial
L2 = 2
delta2 = 6.86
sigma2 = 21.77
zL2 = delta2/sqrt(4/197*sigma2^2)

t2 = des2$secondaryTrial$byStageResults$informationRates[1:L2]

# repeated confidence interval
getADRCI(L = L, zL = zL,
         IMax = n/(4*sigma1^2), kMax = 3,
         informationRates = t,
         alpha = 0.05, typeAlphaSpending = "sfHSD",
         parameterAlphaSpending = -4,
         L2 = L2, zL2 = zL2,
         INew = n2/(4*sigma2^2),
         MullerSchafer = TRUE,
         informationRatesNew = t2,
         typeAlphaSpendingNew = "sfHSD",
         parameterAlphaSpendingNew = -2)

</code></pre>


</div>